Skip to content

Nationwide Implementation of Standardized Structured Reporting

Nationwide Implementation of Standardized Structured Reporting to Support Optimal Treatment Decisions

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03649126
Acronym
IMPROVING
Enrollment
50
Registered
2018-08-28
Start date
2018-08-21
Completion date
2020-06-30
Last updated
2018-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Standardized Structured Reporting

Keywords

standardized structured reporting, treatment decisions, multidisciplinary team, pathology, implementation tools

Brief summary

The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines

Detailed description

By implementing SSR in various disciplines, we contribute to improving communication, efficiency and quality of multidisciplinary team (MDT) meetings and facilitate optimal treatment decision making. Optimal discussion of each patient at MDT meetings can be achieved by a clear communication of all diagnostic results among MDT members. However, the adoption of innovations, such as SSR, is laborious, especially when the innovation requires changing daily habits. Offering implementation tools supports the adoption of innovations among medical professionals. Implementation tools are most effective when they are developed on the basis of factors that impede or facilitate the innovation. Besides the importance of investigating these factors for SSR among pathologists, we will also involve MDT members receiving pathology SSRs in our study. After all, because MDT members will greatly benefit from SSR, they could play a key role in stimulating the use of SSR among pathologists. Therefore, we will also explore which tools MDT members need to stimulate the diagnostic disciplines in using SSR. Subsequently, we will develop and evaluate implementation tools to support the use of SSR by pathologists. The kit for successful implementation of SSR will be offered to other medical disciplines like radiology, endoscopy, and surgery who face similar challenges with implementation of SSR. The SSR-kit consists of our multidisciplinary approach for the whole process of developing implementation tools for SSR, examples of tools for SSR, and other results of this project.

Interventions

Implementation tools developed by experts in order to increase the use of SSR in pathology

Sponsors

Dutch Cancer Society
CollaboratorOTHER
PALGA foundation
CollaboratorOTHER
Radboud University Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
Yes

Inclusion criteria

* Pathologists of urological, gynecological or gastro-intestinal cancers * Other MDT-members of urological, gynecological or gastro-intestinal cancers (medical oncologists, radiologists, radiotherapists, urologists, gynecologists, intestinal surgeons, nuclear medicine physicians, nurse practitioners). * Dutch * Residents

Exclusion criteria

* Retirees

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of implementation tools - frequencies of use of SSR templates in pathology in the Netherlands6 monthsThe improvement in use of SSR templates in the Netherlands (=effectiveness of implementation tools) measured by frequencies of use of SSR templates in pathology (=all laboratories in the Netherlands)
Barriers and facilitators in implementation of SSR in MDT - focus groups and self-developed questionnaire9 monthsBarriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire

Secondary

MeasureTime frameDescription
Determinants of barriers and facilitators in implementation of SSR - focus groups and a self-developed questionnaire1 monthDeterminants of barriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire
Experiences with implementation tools - questionnaire6 monthsExperiences of pathologists and other MDT members with the implementation tools, measured by a questionnaire
Use of implementation tools - questionnaire6 monthsUse of implementation tools among pathologists and other MDT members, measured by a questionnaire

Countries

Netherlands

Contacts

Primary ContactJulie Swillens, MSc
Julie.Swillens@radboudumc.nl+31-615343689
Backup ContactRosella Hermens, PhD
Rosella.Hermens@radboudumc.nl+ 31 24 36 15305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026